Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries: Page 5
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Formulas/Products
Multimedia
News
Regulations
Claims/Labeling
Research
Testing
Enter search phrase
Search
115 Results
Section: Regulations > Claims/Labeling
Claims/Labeling
Back to Basics IV: Product Labeling, Manufacturing and Launch
The development of a new cosmetic product is an extensive, multistep process, from idea generation to market launch. This fourth article in a series explores the rules for later steps in the process: claims, labeling and manufacturing. Click through to the digital magazine for more.
Regional
New Year, New Regulations: Brexit and UK Cosmetic Legislation
When Jan. 1, 2021 arrived, it was the start of updated and revised regulations in the European Union (EU); specifically, in the United Kingdom (UK). Herein, the author delves into UK regulatory updates, which include Responsible Person(s), labeling and more.
Claims/Labeling
FDA Warns About Stimulating Collagen, Lightening and Other Claims
This article reminds us that the FDA has issued a warning about claims which would imply certain cosmetics would be considered drugs under the Federal Food, Drug and Cosmetic Act.
Claims/Labeling
FDA and Academia: Institutions to Collaborate Under Nanotech Initiative
Over-arching goals have spurred a collaboration to develop safe and effective nano-engineered products. While these efforts concentrate on medical use, implications for personal care are on the horizon.
Event Coverage
[in-cosmetics Global] Social Responsibility, Empowerment and Measuring Up
Perhaps one of the most novel aspects of sustainability presented at in-cosmetics this year was how to measure it.
Color Cosmetics
The Top Color Cosmetic Claims, Benefits and Ingredients Among Consumers
Cherry Pick tracked social media engagement and compiled the top claims, benefits and key ingredients currently attracting beauty lovers.
Claims/Labeling
Translating Data into Claims and Interpreting Regulations: Science vs. Marketing
Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.
Consumers/Market
What’s in My Jar Analyzes Product Efficacy and Irritant Potential
What’s in My Jar is an app that analyzes unsubsidized company claims and marketing language for skin care products to educate consumers about how effective or potentially irritating products are.
Methods/Tools
IFSCC 2014 Explores Social, Psychological and Sensorial Aspects of Beauty
As one might expect from an event centered around beauty and staged in Paris, the 28th Congress of the International Societies of Cosmetic Chemists (IFSCC) was nothing less than fabulous. However, the glamour and fanfare was deeply rooted in science.
Claims/Labeling
Translating Data into Claims and Interpreting Regulations: Science vs. Marketing
Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.
Event Coverage
General Assembly Discusses Endocrine Disruptors, Nano, Animal Alternatives and More
Cosmetics Europe—The Personal Care Association, formerly Colipa, held its annual General Assembly in Brussels, Belgium in June 2012. The scientific forum discussed topics of interest in EU legislation such as The Cosmetics Regulation, which was set to replace the Cosmetics Directive on July 11, 2013.
Claims/Labeling
J&J Voluntarily Recalls Benzene-containing Neutrogena and Aveeno Spray Sunscreens
Johnson & Johnson Consumer Inc. is voluntarily recalling all lots of five Neutrogena and Aveeno aerosol sunscreens as some were found to contain low levels of benzene.
Regional
FDA Closes Negotiations with ICMAD and PCPC, Prompting Industry Response
On Mar. 6, 2014, Michael Taylor, on behalf of th The U.S. Food and Drug Administration (FDA), responded to the Proposed Draft Legislation by the Personal Care Product's Council (PCPC) and the Independent Cosmetics Manufacturers and Distributors (ICMAD), effectively finding no common ground between the three and closing the negotiation.
Regional
NSF Launches Testing, Certification and Consulting Program for Cosmetic Safety
Global public health organization NSF International has launched the NSF Cosmetics and Personal Care Program in response to growing concerns from consumers and retailers regarding adulteration, mislabeling and counterfeiting issues.
Regional
Cosmetovigilance and Safety Assessment in the World of Active Ingredients
It can be deduced from today's scientific literature that countless ingredients have been developed with the intent to alter the structure and function of human skin. This raises important questions in terms of how these products should be regulated and what types of safety standards they should be held to.
Regional
FDA Flags Color Additive, SPF and Contaminant Offenses, Urges 'Recall Readiness'
In recent months, the U.S. Food and Drug Administration (FDA) reported six voluntary recalls for an impermissible color additive, mislabeled SPF and several contaminants. It also urged companies to be "recall ready" and provided final guidance to do so.
Claims/Labeling
Pick and Choose—Balancing Sunscreen Benefits: Sun Protection or Vitamin D?
It’s well-known that over-exposure to UV light is harmful to the body, yet it is vital for production of essential vitamin D. Understanding the balance between the benefits of sun protection and vitamin D synthesis is not yet well understood.
Regional
PCPC/FDA Briefing: VOCs, CBD, PFAs, Talc and the Safe Cosmetics Act
VOCs, CBD, 1,4-dioxane, talc, transparency, PFAs, formaldehyde, allergens and the Safe Cosmetics Act are among the top current areas of focus for the PCPC and FDA. These and other topics were discussed during the PCPC's virtual summit, held May 11-13, 2021.
Previous Page
Page 5 of 7
Next Page